Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Oct-24 4:07 PM View:  | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 30-Sep-24 | Planned Option Sale | 35,846 | $40.03 | $1,434,950.00 | (100%) 35.85K to 0 | |
| 01-Oct-24 4:07 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 30-Sep-24 | Option Exercise | 35,846 | $24.00 | $860,304.00 | 100% 0 to 35.85K | |
| 30-Sep-24 4:03 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 27-Sep-24 | Option Exercise | 200 | $24.00 | $4,800.00 | 100% 0 to 0.2K | |
| 30-Sep-24 4:03 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 27-Sep-24 | Planned Option Sale | 200 | $40.04 | $8,009.00 | (100%) 0.2K to 0 | |
| 02-Apr-24 4:31 PM View: | Kapadia Sandip Chief Financial Officer | Harmony Biosciences Holding... (HRMY) | 29-Mar-24 | Payment of Exercise | 8,013 | $33.58 | $269,077.00 | (53%) 15.0K to 6.99K | |
| 02-Apr-24 4:31 PM View: | Kapadia Sandip Chief Financial Officer | Harmony Biosciences Holding... (HRMY) | 29-Mar-24 | Option Exercise | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 18-Mar-24 7:24 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 15-Mar-24 | Option Exercise | 11,979 | $8.22 | $98,467.40 | 100% 0 to 11.98K | |
| 18-Mar-24 7:24 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 15-Mar-24 | Planned Option Sale | 11,979 | $32.00 | $383,328.00 | (100%) 11.98K to 0 | |
| 11-Mar-24 5:17 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 08-Mar-24 | Planned Option Sale | 194 | $32.00 | $6,208.00 | (100%) 0.19K to 0 | |
| 11-Mar-24 5:17 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 08-Mar-24 | Option Exercise | 194 | $8.22 | $1,594.68 | 100% 0 to 0.19K | |
| 31-Mar-23 4:26 PM View: | Kapadia Sandip Chief Financial Officer | Harmony Biosciences Holding... (HRMY) | 29-Mar-23 | Option Exercise | 30,000 | -- | -- | 100% 0 to 30.0K | |
| 31-Mar-23 4:26 PM View: | Kapadia Sandip Chief Financial Officer | Harmony Biosciences Holding... (HRMY) | 29-Mar-23 | Payment of Exercise | 15,414 | $33.36 | $514,211.00 | (51%) 30.0K to 14.59K | |
| 16-Dec-22 7:15 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 14-Dec-22 | Private Sale (Planned) | 2,834 | $59.96 | $169,927.00 | (< 1%) 2.57M to 2.57M | |
| 14-Dec-22 9:01 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 14-Dec-22 | Sale | 130 | $60.00 | $7,800.00 | (< 1%) 2.15M to 2.15M | |
| 14-Dec-22 9:01 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 13-Dec-22 | Sale | 6,320 | $60.13 | $380,022.00 | (< 1%) 2.15M to 2.15M | |
| 14-Dec-22 9:01 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 12-Dec-22 | Private Sale | 22,391 | $60.36 | $1,351,520.00 | (1%) 2.18M to 2.15M | |
| 09-Dec-22 8:34 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 09-Dec-22 | Sale (Planned) | 9,847 | $59.89 | $589,737.00 | (< 1%) 2.58M to 2.57M | |
| 09-Dec-22 8:34 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 08-Dec-22 | Sale (Planned) | 36,878 | $59.90 | $2,208,990.00 | (1%) 2.62M to 2.58M | |
| 09-Dec-22 8:34 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 07-Dec-22 | Private Sale (Planned) | 64,026 | $60.35 | $3,863,970.00 | (2%) 2.68M to 2.62M | |
| 07-Dec-22 9:00 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 05-Dec-22 | Private Sale | 77,853 | $61.23 | $4,766,940.00 | (3%) 2.25M to 2.18M | |
| 05-Dec-22 4:10 PM View: | Serafin Andrew CHIEF STRATEGY OFFICER | Harmony Biosciences Holding... (HRMY) | 02-Dec-22 | Option Exercise | 38,000 | $8.22 | $312,360.00 | 100% 0 to 38.0K | |
| 05-Dec-22 4:10 PM View: | Serafin Andrew CHIEF STRATEGY OFFICER | Harmony Biosciences Holding... (HRMY) | 02-Dec-22 | Planned Option Sale | 38,000 | $60.13 | $2,285,100.00 | (100%) 38.0K to 0 | |
| 01-Dec-22 7:52 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 01-Dec-22 | Sale (Planned) | 65,652 | $60.00 | $3,939,120.00 | (2%) 2.75M to 2.68M | |
| 01-Dec-22 7:52 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 30-Nov-22 | Sale (Planned) | 42,667 | $58.93 | $2,514,370.00 | (2%) 2.79M to 2.75M | |
| 01-Dec-22 7:52 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 29-Nov-22 | Private Sale (Planned) | 21,333 | $57.82 | $1,233,470.00 | (< 1%) 2.81M to 2.79M | |
| 22-Nov-22 8:57 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 22-Nov-22 | Sale (Planned) | 31,902 | $57.60 | $1,837,560.00 | (1%) 2.85M to 2.81M | |
| 22-Nov-22 8:57 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 21-Nov-22 | Sale (Planned) | 24,898 | $57.08 | $1,421,180.00 | (< 1%) 2.87M to 2.85M | |
| 22-Nov-22 8:57 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 18-Nov-22 | Private Sale (Planned) | 20,800 | $57.00 | $1,185,600.00 | (< 1%) 2.89M to 2.87M | |
| 15-Nov-22 6:26 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 15-Nov-22 | Sale (Planned) | 62,933 | $56.80 | $3,574,590.00 | (2%) 2.95M to 2.89M | |
| 16-Nov-22 9:31 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 15-Nov-22 | Sale | 10,961 | $60.10 | $658,756.00 | (< 1%) 2.27M to 2.25M | |
| 16-Nov-22 9:31 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 14-Nov-22 | Private Sale | 40,317 | $59.10 | $2,382,730.00 | (2%) 2.31M to 2.27M | |
| 15-Nov-22 6:26 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 14-Nov-22 | Sale (Planned) | 58,667 | $58.70 | $3,443,750.00 | (2%) 3.01M to 2.95M | |
| 15-Nov-22 6:26 PM View: | Nielsen Jack Director | Harmony Biosciences Holding... (HRMY) | 11-Nov-22 | Private Sale (Planned) | 36,800 | $57.14 | $2,102,750.00 | (1%) 3.05M to 3.01M | |
| 10-Nov-22 9:04 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 10-Nov-22 | Sale | 95,242 | $58.80 | $5,600,230.00 | (4%) 2.4M to 2.31M | |
| 10-Nov-22 9:04 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 09-Nov-22 | Sale | 15,301 | $58.05 | $888,223.00 | (< 1%) 2.42M to 2.4M | |
| 10-Nov-22 9:04 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 08-Nov-22 | Private Sale | 18,865 | $60.01 | $1,132,090.00 | (< 1%) 2.44M to 2.42M | |
| 04-Nov-22 9:00 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 04-Nov-22 | Sale | 157,950 | $58.81 | $9,289,040.00 | (6%) 2.59M to 2.44M | |
| 04-Nov-22 4:05 PM View: | Dayno Jeffrey M. Chief Medical Officer | Harmony Biosciences Holding... (HRMY) | 03-Nov-22 | Planned Option Sale | 15,000 | $60.02 | $900,332.00 | (100%) 15.0K to 0 | |
| 04-Nov-22 9:00 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 03-Nov-22 | Sale | 254,141 | $59.44 | $15,106,100.00 | (9%) 2.85M to 2.59M | |
| 04-Nov-22 4:05 PM View: | Dayno Jeffrey M. Chief Medical Officer | Harmony Biosciences Holding... (HRMY) | 03-Nov-22 | Option Exercise | 15,000 | $8.22 | $123,300.00 | 100% 0 to 15.0K | |
| 04-Nov-22 9:00 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 02-Nov-22 | Private Sale | 164,676 | $58.81 | $9,684,600.00 | (5%) 3.01M to 2.85M | |
| 02-Nov-22 4:04 PM View: | Dayno Jeffrey M. Chief Medical Officer | Harmony Biosciences Holding... (HRMY) | 01-Nov-22 | Option Exercise | 15,000 | $8.22 | $123,300.00 | 100% 0 to 15.0K | |
| 02-Nov-22 4:04 PM View: | Dayno Jeffrey M. Chief Medical Officer | Harmony Biosciences Holding... (HRMY) | 01-Nov-22 | Planned Option Sale | 15,000 | $55.10 | $826,558.00 | (100%) 15.0K to 0 | |
| 04-Oct-22 4:07 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 03-Oct-22 | Planned Option Sale | 12,173 | $44.68 | $543,916.00 | (100%) 12.17K to 0 | |
| 04-Oct-22 4:07 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 03-Oct-22 | Option Exercise | 12,173 | $8.22 | $100,062.00 | 100% 0 to 12.17K | |
| 23-Aug-22 4:11 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 22-Aug-22 | Planned Option Sale | 28,971 | $47.00 | $1,361,730.00 | (100%) 28.97K to 0 | |
| 23-Aug-22 4:11 PM View: | Dierks Jeffrey Chief Commercial Officer | Harmony Biosciences Holding... (HRMY) | 22-Aug-22 | Option Exercise | 28,971 | $24.00 | $695,304.00 | 100% 0 to 28.97K | |
| 16-Aug-22 4:04 PM View: | Jacobs John C President, CEO Director | Harmony Biosciences Holding... (HRMY) | 15-Aug-22 | Option Exercise | 40,000 | $8.22 | $328,800.00 | 100% 0 to 40.0K | |
| 16-Aug-22 4:04 PM View: | Jacobs John C President, CEO Director | Harmony Biosciences Holding... (HRMY) | 15-Aug-22 | Planned Option Sale | 40,000 | $51.07 | $2,042,810.00 | (100%) 40.0K to 0 | |
| 10-Aug-22 9:23 PM View: | Wicki Andreas Director | Harmony Biosciences Holding... (HRMY) | 10-Aug-22 | Sale | 71,447 | $52.61 | $3,758,830.00 | (2%) 3.08M to 3.01M |
